Business Weekly, published its 1949th issue on March 20, 2025, exploring the rising trend of exosome products. Dr. Yi-Pei Hung, General Manager of UnicoCell Biomed, shared her insights on the safety of exosome products and the current market landscape. She emphasized UnicoCell completed multiple rigorous safety testing for exosome products, proving our commitment to the safety evaluation and efficacy data of exosomes. The following content is excerpt from Dr. Hung's interview which is highlighted in the blue box below:"Unicocell not only supplies exosome products, manufactured by patented process, as cosmetic materials, but also collaborates with Mentor Group, the largest hair salon chain in Taiwan, to launch hair care application. Clients specifically request data such as the cell source of exosome production, certificate of the production facility , information of concentration and purity levels. Some international cosmetic companies even voluntarily disclose such information in their product descriptions. Since exosome products are relatively new to the market, they must meet general cosmetic safety standards. Moreover, when claiming efficacy, there should be sufficient data to convince consumers."
Business Weekly, founded in 1987, is Taiwan’s leading business and financial media outlet, renowned for its credibility, authority, and in-depth reporting. It has long held an influential position in the business community, offering precise industry insights and trend forecasts. As a trusted source, it is a must-read for business leaders and industry professionals.
Excerpt from Business Weekly (1949th issue) : Exosome Trend (2025.03.20)
UnicoCell Biomed Co.,Ltd.
Contact: Ray Liu
Phone: 886-2-27922699
Mail: info@unicocell.com